(NYSE:DOOR), LOS ANGELES, March 03, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Masonite International Corporation (“Masonite” or “the Company”) (NYSE: DOOR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by […]

DOOR Investors Have Opportunity to Lead Masonite International Corporation Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire March 03, 2026 LOS ANGELES, March 03, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Masonite International Corporation (“Masonite” or “the Company”) (NYSE:

(NASDAQ:RARE), LOS ANGELES, March 03, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or “the Company”) (NASDAQ: RARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

(NASDAQ:MREO), LOS ANGELES, March 03, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mereo BioPharma Group plc (“Mereo” or “the Company”) (NASDAQ: MREO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire March 03, 2026 LOS ANGELES, March 03, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or “the Company”) (NASDAQ:

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire March 03, 2026 LOS ANGELES, March 03, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mereo BioPharma Group plc (“Mereo” or “the

(NasdaqGM:AIPO), MIAMI, March 03, 2026 (GLOBE NEWSWIRE) — Defiance ETFs today announced that the Defiance AI & Power Infrastructure ETF (Nasdaq: AIPO) has surpassed $200 million in assets under management. The fund is up approximately +20.10%* year-to-date, while the Nasdaq-100 Index is down approximately -0.85% over the same period, based on data from Bloomberg as

(NASDAQ:RCT), LONDON, March 03, 2026 (GLOBE NEWSWIRE) — RedCloud Holdings plc (NASDAQ: RCT) (“RedCloud” or the “Company”), the technology company building intelligent infrastructure for global trade, today announced it has surpassed 100,000 customers globally, including retailers, wholesalers and distributors. This marks a significant scale milestone as the Company accelerates deployment of its agentic AI infrastructure

Southern Pines, NC, March 03, 2026 (GLOBE NEWSWIRE) — SOUTHERN PINES, NC– Lisa Bradley, CEO & Co-founder of R.Riveter has been named a winner of the 2026 Enterprising Women of the Year Awards, an annual tribute to the world's top women entrepreneurs. Bradley will be recognized at the 24th Annual Enterprising Women of the Year

AIPO, the First ETF Focused on AI Power, Surpasses $200M in AUM GlobeNewswire March 03, 2026 MIAMI, March 03, 2026 (GLOBE NEWSWIRE) — Defiance ETFs today announced that the Defiance AI & Power Infrastructure ETF (Nasdaq: AIPO) has surpassed $200 million in assets under management. The fund is up approximately +20.10%* year-to-date, while the Nasdaq-100